An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population

An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population

Introduction: Most Parkinson’s disease (PD) medication adherence studies have focused on patients with commercial or Medicare health insurance coverage. However, less is known regarding medication treatment patterns within the Medicaid population. Methods: This retrospective cohort study utilized 20...

Full description

Bibliographic Details
Main Authors:	Michael Johnsrud, Kristin Richards, Steve Arcona, Rahul Sasané, Matthew Leoni
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Clinical Parkinsonism & Related Disorders
Subjects:	Parkinson’s disease Medicaid Medication adherence Levodopa Dopamine agonist
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590112521000219

Similar Items

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
by: Vinod Metta, et al.
Published: (2020-01-01)

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
by: Szász JA, et al.
Published: (2019-04-01)

Levodopa enhances reward learning but impairs reversal learning in Parkinson’s disease patients
by: Ahmed A. Moustafa
Published: (2011-01-01)

Dopaminergic medication modulates learning from feedback and error-related negativity in Parkinson’s disease: a pilot study
by: Chiara Volpato, et al.
Published: (2016-10-01)

Pregnancy in Parkinson's disease with PARK2 mutations
by: Ali Sazci, et al.
Published: (2019-01-01)

Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
by: E. Maruthi Prasad, et al.
Published: (2021-07-01)

Adesão à medicação em pacientes com doença de Parkinson atendidos em ambulatório especializado Adherence to medication among patients with Parkinson's disease treated at a specialized outpatient unit
by: José Alexandre de Souza Crippa, et al.
Published: (2013-03-01)

The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease
by: Marina Romanovna Nodel
Published: (2013-11-01)

Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
by: Ana Muñoz, et al.
Published: (2020-06-01)

Gender Differences and Quality of Life in Parkinson’s Disease
by: Pietro Crispino, et al.
Published: (2021-12-01)

Practical aspects of prescribing antiparkinsonian drugs. The place of amantadines in the management of Parkinson’s disease
by: N. V. Titova, et al.
Published: (2021-03-01)

D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism
by: Bérangère Ballion, et al.
Published: (2009-09-01)

Medicaid Payment Systems: Impact On Quality Of Care, Medication Adherence And Healthcare Service Utilizations In Type 2 Diabetes Medicaid Enrollees
by: Pawaskar, Manjiri D.
Published: (2008)

Current therapy for Parkinson's disease
by: A. V. Obukhova
Published: (2014-10-01)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
by: Fatma Haddad, et al.
Published: (2017-12-01)

Efeito da levodopa na mecânica coclear e no sistema auditivo eferente de indivíduos com doença de Parkinson
by: Marcia da Silva Lopes, et al.
Published: (2019-02-01)

The Medicaid evolution : the political economy of Medicaid federalism
by: Eldridge, Gloria Nicole, 1972-
Published: (2011)

The Medicaid evolution: the political economy of Medicaid federalism
by: Eldridge, Gloria Nicole
Published: (2008)

Medicaid: An Overview
by: Gilbert Berdine
Published: (2013-10-01)

Parkinsonism in Association with Dihydropteridine Reductase Deficiency
by: Yoshiaki Takahashi, et al.
Published: (2017-02-01)

Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease
by: A. A. Tappakhov, et al.
Published: (2020-02-01)

IMPULSIVE-COMPULSIVE DISORDERS IN PARKINSON'S DISEASE. CLINICAL CASES
by: N. V. Fedorova, et al.
Published: (2015-10-01)

Medication utilization, adherence and use of relief agents among Texas medicaid patients with persistent asthma
by: Makhinova, Tatiana Victorovna
Published: (2014)

Pain in Parkinson's disease Dor na doença de Parkinson
by: Grace Helena Letro, et al.
Published: (2009-09-01)

LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01)

Improving Therapeutics for Parkinson's Disease
by: O'Malley, Jennifer A.
Published: (2009)

Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
by: Mohammad Edrees Mohammad, et al.
Published: (2021-01-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study
by: Nicola J. Ray, et al.
Published: (2012-12-01)

Dopamine Agonists Exert Nurr1-inducing Effect in Peripheral Blood Mononuclear Cells of Patients with Parkinson′s Disease
by: Li-Min Zhang, et al.
Published: (2015-01-01)

Mathematical insights into the effects of levodopa
by: Michael C. Reed, et al.
Published: (2012-07-01)

The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias
by: Vishakh Iyer, et al.
Published: (2021-11-01)

Sleep disturbances in drug naïve Parkinson′s disease (PD) patients and effect of levodopa on sleep
by: Teresa Ferreira, et al.
Published: (2014-01-01)

Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease
by: S N Illarioshkin
Published: (2012-06-01)

Excessive Daytime Sleepiness and Unintended Sleep Episodes Associated with Parkinson’s Disease
by: Fatai Salawu, et al.
Published: (2015-01-01)

Comparison of Orthodontic Medicaid Funding in the United States 2006 to 2015
by: Gerald Minick, et al.
Published: (2017-08-01)

Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease
by: Miguel M. Carvalho, et al.
Published: (2017-08-01)

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data
by: Albert J. Farias, et al.
Published: (2018-12-01)

USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01)